Tag Archives: provided sufficient evidence
Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million
Celgene Corporation, a biotech company based in New Jersey, will pay out $280 million to settle claims that it cited uses not approved by the U.S. Food and Drug Administration (FDA) in promotion of its cancer treatment drugs Thalomid and Fevlimid. According to Judge George H. King, the plaintiff “provided sufficient evidence” that the corporation […]
